Antibody Investments LLC 3
3 · VACCINEX, INC. · Filed Aug 9, 2018
Insider Transaction Report
Form 3
VACCINEX, INC.VCNX
Antibody Investments LLC
10% Owner
Holdings
Series C Convertible Preferred Stock
→ Common Stock (1,346,139 underlying)Series D Convertible Preferred Stock
→ Common Stock (549,444 underlying)
Footnotes (2)
- [F1]The reported securities will convert into shares of Common Stock on a 0.1868-for-1 basis immediately prior to the consummation of the Issuer's initial public offering.
- [F2]The reported securities will convert into shares of Common Stock on a 1-for-10 basis immediately prior to the consummation of the Issuer's initial public offering.